Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 103 (RNA5SP103)

Target
RNA5SP103
Molecular classification
Other (Pseudogene, non-coding RNA pseudogene, specifically rRNA processed pseudogene)
01

Overview

RNA, 5S ribosomal pseudogene 103 is a non-functional genetic element within the human genome classified as a rRNA processed pseudogene. It is derived from the 5S ribosomal RNA gene but does not produce functional rRNA. While the parental 5S rRNA gene is essential for the large ribosomal subunit function in protein synthesis[1][3], pseudogenes such as RNA5SP103 typically arise through retrotransposition, lose their original function, and may be transcribed at low or undetectable levels[2][4][6]. Some pseudogenes exhibit minor regulatory capacities—such as acting as miRNA decoys or producing non-coding RNA with potential interference activity—but these functions are rare and poorly characterized for 5S rRNA pseudogenes[4]. RNA, 5S ribosomal pseudogene 103 is not recognized as a receptor, enzyme, transporter, or therapeutic target, and is not relevant for disease association, biomarker, or drug targeting efforts.\n\nIf you are seeking information for actionable or druggable targets, 5S rRNA itself is a structural RNA and not targeted for therapy; the pseudogene variant RNA5SP103 is simply an inert genomic locus[1][2].

Other names
RN5S103RNA5SP103RNA, 5S ribosomal 103
02

Biological functions

Other (Processed pseudogenes may have minor regulatory roles via RNA interference, antisense interaction, or miRNA decoy functions, but RNA5SP103 is not expected to encode a functional 5S rRNA or protein)
03

Disease associations

Other (There is no evidence linking RNA5SP103 to specific diseases; generally, most pseudogenes are not causative for disease, though some may have subtle regulatory roles in rare contexts)

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 103 (RNA5SP103).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 103 (RNA5SP103).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call